FDA Inspection 1205037 — BioLyte Laboratories, LLC
The FDA completed an inspection of BioLyte Laboratories, LLC on Apr 27, 2023 in Grand Rapids, MI. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 27, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Grand Rapids, MI (United States)